Log In
Print
BCIQ
Print
Print this Print this
 

Sitavig (acyclovir Lauriad, Sitavir) (BA-021)

  Manage Alerts
Collapse Summary General Information
Company BioAlliance Pharma S.A.
DescriptionMucoadhesive formulation of acyclovir
Molecular Target
Mechanism of ActionAntiviral agent
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationHerpes simplex virus (HSV)
Indication DetailsTreat recurrent herpes labialis; Treat recurrent orofacial herpes
Regulatory Designation

U.S. - Undisclosed Review (Treat recurrent orofacial herpes)

Partner

Daewoong Pharmaceutical Co. Ltd.; Innocutis Holdings LLC; Teva Pharmaceutical Industries Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today